Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades.

The Mumbai-based drug major, in a statement, said it has launched Fexuprazan tablets (40 mg) in India under the brand name Fexuclue, a novel potassium-competitive acid blocker (PCAB).

The product is approved as a new treatment for adults with Erosive Esophagitis of all grades, it added.

As per the agreement terms, Daewoong will be entitled to upfront and milestone payments, including royalties, it said.

“Erosive Esophagitis is a serious condition that greatly affects patients’ quality of life. Despite available treatments, there remains a significant unmet need in its management. Fexuclue is a best-in-class treatment option with the potential to bridge this gap,” Sun Pharma CEO India Business Kirti Ganorkar stated.

Fexuprazan was evaluated in a double-blind, double-dummy, comparative Phase 3 study in the adult Indian population.

The primary efficacy measure was the healing of Erosive Esophagitis, which was confirmed endoscopically.

The study met its primary endpoint. Over 95 per cent of the patients achieved Erosive Esophagitis healing by 8 weeks, the drug maker said.

Related Posts

  • Pharma
  • July 15, 2025
  • 117 views
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

  • Pharma
  • July 15, 2025
  • 142 views
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR